---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-000328"
form_type: "8-K"
ticker: null
cik: "0001622057"
company_name: "Nascent Biotech Inc."
filed_at: "2025-01-17T23:59:59+00:00"
generated_at: "2026-05-27T23:15:03.044608+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nascent Biotech director resigns; company faces OTC delinquency for late filing

## Summary
- Douglas Karas resigned as independent director on Jan 10, 2025 due to personal health issues.
- Company received OTC delinquency for untimely filing; will file Q3 2025 (likely Q3 2024) to maintain pink sheet status.
- Directors and officers agreed to terminate non-dilutive stock clause in employment contracts.

## SEC filing metadata
- accession: 0001477932-25-000328
- form_type: 8-K
- cik: 0001622057
- company_name: Nascent Biotech Inc.
- filed_at: 2025-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622057/000147793225000328/0001477932-25-000328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622057/000147793225000328/nbio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-000328
- JSON: https://secwatch.observer/filing/0001477932-25-000328.json
- Plain text: https://secwatch.observer/filing/0001477932-25-000328.txt

## Key facts
- Executive change
  Douglas Karas resigned as independent Director at Nascent Biotech Inc..
  - Action: resigned
  - Role: independent Director
  source text: On January 10, 2025, Douglas Karas submitted his written resignation as an independent Director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1622057/000147793225000328/0001477932-25-000328-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.